Matches in SemOpenAlex for { <https://semopenalex.org/work/W3163719982> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W3163719982 endingPage "527" @default.
- W3163719982 startingPage "521" @default.
- W3163719982 abstract "Thirty-seven patients with advanced gastroenteropancreatic neuroendocrine tumors (GEPNETs) were treated on a prospective phase II single-center study with four cycles of 7.8 GBq 177Lu-octreotate combined with capecitabine and temozolomide chemotherapy (CAPTEM). Each 8-week cycle combined radiopeptide therapy with 14 days of capecitabine (1500 mg/m2) and 5 days of temozolomide (200 mg/m2). The incidence of grade ≥ 3 hematologic toxicity was analyzed. At a median follow-up of 7-years (range 1-10), six (16%) patients developed persistent hematologic toxicity (PHT) (defined as sustained grade ≥ 3 hematologic toxicity beyond 36-months follow-up) and three (8%) developed MDS/AL with a median time-to-event of 46 and 34 months, respectively. The estimated cumulative incidence of MDS/AL was 11% (95% CI: 3.45-24.01). Development of PHT was the only significant risk factor for secondary MDS/AL (RR, 16; 95% CI: 2.53 to 99.55; P < 0.001). The median PFS was 48 months (95% CI: 40.80-55.20), and the median OS was 86 months (95% CI: 56.90-115.13). Twenty-one deaths were recorded, including 13 (62%) due to progressive disease and all 3 (14%) patients with MDS/AL. 177Lu-octreotate CAPTEM therapy for GEPNETs is associated with a risk of long-term hematologic toxicity. The rising cumulative incidence of MDS/AL > 10% mandates the long-term monitoring of treated patients. However, time to onset is unpredictable, and incidence does not correlate with conventional baseline risk factors. Novel methods are required for the stratification of prospective patients based on genetic risk." @default.
- W3163719982 created "2021-05-24" @default.
- W3163719982 creator A5004878890 @default.
- W3163719982 creator A5040581148 @default.
- W3163719982 creator A5050960969 @default.
- W3163719982 creator A5066660671 @default.
- W3163719982 creator A5086752045 @default.
- W3163719982 date "2021-07-01" @default.
- W3163719982 modified "2023-09-27" @default.
- W3163719982 title "Long-term hematologic toxicity of 177Lu-octreotate-capecitabine-temozolomide therapy of GEPNET" @default.
- W3163719982 cites W1453000988 @default.
- W3163719982 cites W2006830353 @default.
- W3163719982 cites W2012856564 @default.
- W3163719982 cites W2090257199 @default.
- W3163719982 cites W2148881212 @default.
- W3163719982 cites W2469875234 @default.
- W3163719982 cites W2590193878 @default.
- W3163719982 cites W2846786516 @default.
- W3163719982 cites W2890153608 @default.
- W3163719982 cites W2891986888 @default.
- W3163719982 cites W2898533025 @default.
- W3163719982 cites W3029452609 @default.
- W3163719982 cites W3045230440 @default.
- W3163719982 cites W587945571 @default.
- W3163719982 doi "https://doi.org/10.1530/erc-21-0082" @default.
- W3163719982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34010146" @default.
- W3163719982 hasPublicationYear "2021" @default.
- W3163719982 type Work @default.
- W3163719982 sameAs 3163719982 @default.
- W3163719982 citedByCount "9" @default.
- W3163719982 countsByYear W31637199822021 @default.
- W3163719982 countsByYear W31637199822022 @default.
- W3163719982 countsByYear W31637199822023 @default.
- W3163719982 crossrefType "journal-article" @default.
- W3163719982 hasAuthorship W3163719982A5004878890 @default.
- W3163719982 hasAuthorship W3163719982A5040581148 @default.
- W3163719982 hasAuthorship W3163719982A5050960969 @default.
- W3163719982 hasAuthorship W3163719982A5066660671 @default.
- W3163719982 hasAuthorship W3163719982A5086752045 @default.
- W3163719982 hasConcept C120665830 @default.
- W3163719982 hasConcept C121332964 @default.
- W3163719982 hasConcept C121608353 @default.
- W3163719982 hasConcept C126322002 @default.
- W3163719982 hasConcept C141071460 @default.
- W3163719982 hasConcept C151032500 @default.
- W3163719982 hasConcept C188816634 @default.
- W3163719982 hasConcept C2776694085 @default.
- W3163719982 hasConcept C2777389519 @default.
- W3163719982 hasConcept C2777909004 @default.
- W3163719982 hasConcept C29730261 @default.
- W3163719982 hasConcept C526805850 @default.
- W3163719982 hasConcept C61511704 @default.
- W3163719982 hasConcept C71924100 @default.
- W3163719982 hasConcept C72563966 @default.
- W3163719982 hasConcept C88879693 @default.
- W3163719982 hasConcept C90924648 @default.
- W3163719982 hasConceptScore W3163719982C120665830 @default.
- W3163719982 hasConceptScore W3163719982C121332964 @default.
- W3163719982 hasConceptScore W3163719982C121608353 @default.
- W3163719982 hasConceptScore W3163719982C126322002 @default.
- W3163719982 hasConceptScore W3163719982C141071460 @default.
- W3163719982 hasConceptScore W3163719982C151032500 @default.
- W3163719982 hasConceptScore W3163719982C188816634 @default.
- W3163719982 hasConceptScore W3163719982C2776694085 @default.
- W3163719982 hasConceptScore W3163719982C2777389519 @default.
- W3163719982 hasConceptScore W3163719982C2777909004 @default.
- W3163719982 hasConceptScore W3163719982C29730261 @default.
- W3163719982 hasConceptScore W3163719982C526805850 @default.
- W3163719982 hasConceptScore W3163719982C61511704 @default.
- W3163719982 hasConceptScore W3163719982C71924100 @default.
- W3163719982 hasConceptScore W3163719982C72563966 @default.
- W3163719982 hasConceptScore W3163719982C88879693 @default.
- W3163719982 hasConceptScore W3163719982C90924648 @default.
- W3163719982 hasIssue "7" @default.
- W3163719982 hasLocation W31637199821 @default.
- W3163719982 hasLocation W31637199822 @default.
- W3163719982 hasOpenAccess W3163719982 @default.
- W3163719982 hasPrimaryLocation W31637199821 @default.
- W3163719982 hasRelatedWork W2076130945 @default.
- W3163719982 hasRelatedWork W2152154338 @default.
- W3163719982 hasRelatedWork W2415666441 @default.
- W3163719982 hasRelatedWork W2748980790 @default.
- W3163719982 hasRelatedWork W2922027774 @default.
- W3163719982 hasRelatedWork W2981196319 @default.
- W3163719982 hasRelatedWork W3163719982 @default.
- W3163719982 hasRelatedWork W3212866738 @default.
- W3163719982 hasRelatedWork W4286298063 @default.
- W3163719982 hasRelatedWork W4307938103 @default.
- W3163719982 hasVolume "28" @default.
- W3163719982 isParatext "false" @default.
- W3163719982 isRetracted "false" @default.
- W3163719982 magId "3163719982" @default.
- W3163719982 workType "article" @default.